4
Changes in Ownership
Pacira BioSciences, Inc. Filed Acc 0001628280-26-074533
Chief Commercial Officer returned 100,934.27 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan Chief Commercial Officer | 2026-11-17 | Returned to the company | −100,934.27 | $36.50 | $3,684,101 | 0 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Teehan Brendan Chief Commercial Officer | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −99,500 | $26.59 | 2036-02-04 | 99,500 | 0 | D: show line 2 in the form |
Loading xslF345X06/wk-form4_1794951403.xml…